News Category
VERAXA Biotech's appointment of Dr. Christoph Erkel as chief scientific officer signals a strategic push to advance its innovative BiTAC technology an...
Earth Science Tech Inc. reported FY2026 revenue of $35.7 million, up from $33.1 million in FY2025, as its vertically integrated B2B-B2C healthcare pla...
SS Innovations International Inc. has helped launch Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, marking a significant...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, is moving toward a Phase 2 trial in multiple sclerosis following FDA clear...
Quantum BioPharma's Lucid-MS, the first drug designed to shield and rebuild myelin, receives FDA clearance for a Phase 2 trial, potentially transformi...
Quantum BioPharma has received FDA clearance to launch a Phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis treatment designed to protect ...
SS Innovations International announced a 79% increase in procedures performed with its SSi Mantra surgical robot and a 42% growth in installed systems...
Helus Pharma CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, providing invest...
Onco-Innovations' CMO discussed the company's lead drug candidate ONC010, which uses synthetic lethality and nanoparticle delivery to target PNKP in c...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, is moving toward a phase 2 trial in multiple sclerosis following FDA clear...
Visory Health, a prescription discount card platform, has been recognized by Fast Company for its innovative workplace culture that empowers employees...
The American Stroke Association's 2026 guideline highlights that stroke recovery should start within 48 hours and continue indefinitely, with personal...
Earth Science Tech Inc. (ETST) has strategically positioned itself for long-term growth by leveraging vertical integration and targeting both B2B and ...
Kairos Pharma's CEO will present a corporate overview at a major investment conference, highlighting the company's progress in developing ENV-105 to c...
A new expert commentary highlights flaws in current UTI diagnostic practices, underscoring the need for advanced testing technologies and the potentia...
Nutriband CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on Sept. 16, 2026, highlighting the company's focus on abuse-deterre...
Silo Pharma announces its participation in the IPAC-RS 2026 Nasal Innovation Forum, where it will discuss advancements in its nose-to-brain drug deliv...
Quantum BioPharma's Lucid-MS, a potential first-in-class treatment for multiple sclerosis, has received FDA clearance for Phase 2 trials, drawing a ne...
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protecting drug candidate for multiple sclerosis, has received FDA clearance to begin a Phase 2 ...
Helus Pharma's CEO will discuss the company's clinical programs and progress at a major investment conference, highlighting its novel serotonergic ago...
Moody Capital Solutions will host its 2026 Disruptive Growth & Life Sciences Conference, a two-day event designed to connect investors with emerging a...
GeoVax Labs supports the new Gavi-funded global mpox vaccine stockpile, emphasizing its GEO-MVA candidate's potential to diversify supply and strength...
The August Wellness Index Report highlights the critical work of translating longevity science into clinical practice, featuring experts and promoting...
Greenland Mines announces a Q4 biotech spin-off, Nasdaq compliance, and acquisition of the Sarfartoq rare earths project, positioning itself as a key ...
Nano-X Imaging Ltd. (NNOX) has partnered with Associated X-Ray Imaging Corp. to distribute its Nanox.ARC system across New England, broadening access ...
SS Innovations International reports strong revenue growth and system installations, positioning its SSi Mantra surgical robot for international expan...
Scinai Immunotherapeutics refocuses its R&D portfolio after ending PC111 license, aiming to boost its NanoAb platform and CDMO business.
Onco-Innovations Ltd. has strengthened its clinical foundation for its lead candidate ONC010 through manufacturing milestones, IND-enabling activities...
Roth Capital Partners will host and sponsor over a dozen investor events from September 2026 to June 2027, including seven ROTH-hosted conferences acr...
OS Animal Health, a subsidiary of OS Therapies, is showcasing its HER2-targeting immunotherapy for canine osteosarcoma at the Moody Capital Solutions ...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS marks a potential breakthrough in MS treatment by targeting myelin repair, offering ...
Researchers at Washington University School of Medicine have advanced laser therapy for brain cancer, offering a less invasive alternative to surgery ...
Ocumetics Technology Corp. has initiated patient recruitment for the Group Two human clinical study of its accommodating intraocular lens, moving beyo...
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS, a drug targeting myelin repair, marks a potential breakthrough in multiple sclerosi...
NanoViricides has registered its Phase II clinical trial for NV-387 Oral Gummies against Ebola in the Pan African Clinical Trials Registry, moving for...
Nutriband received a USPTO Notice of Publication for trademarks related to its abuse-deterrent fentanyl patch, moving closer to full trademark protect...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin Phase 2 testing in multiple sclerosis patients, pot...
Quantum BioPharma's FDA clearance to initiate a Phase 2 trial of Lucid-MS for multiple sclerosis marks a significant step toward a novel therapy that ...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS marks a pivotal step toward a targeted therapy for multiple sclerosis, potentially s...
Tonix Pharmaceuticals announced the promotion of Thomas Englese to Chief Commercial Officer, effective immediately, as the company focuses on expandin...
Synbio International has entered into a strategic licensing and revenue-sharing agreement with MD PHD Wellness, securing exclusive rights to commercia...
AcroMeta Group announced a strategic partnership with Macro HRD SG to acquire a stake in Macro-ATCLS and option an exclusive license for Ambient Tempe...
An expert from New York Institute of Technology emphasizes the importance of flu vaccination and preventive measures as flu season approaches, highlig...
A PMI U.S. executive highlights declining youth tobacco use and the importance of FDA-authorized smoke-free alternatives for adults who cannot quit, e...
AOM Capital's $3.8 million bridge loan to a healthcare firm underscores the growing niche of receivables-backed financing to bridge reimbursement gaps...
Nanox Imaging, through its U.S. subsidiary, has signed a distribution agreement with Associated X-Ray Imaging to broaden access to its FDA-cleared 3D ...
A study of over 5,600 colorectal cancer patients reveals that the timing of brain metastasis development significantly impacts survival, underscoring ...
SS Innovations International's second-quarter revenue surged 39.4% to $13.9 million, with 30 SSi Mantra systems installed, signaling strong global exp...
